Try our Advanced Search for more refined results
September 28, 2012
Ivax LLC v. Celgene Corporation
Case Number:
0:12-cv-61917
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
May 08, 2013
Celgene Loses Sanctions Bid Against Teva Unit In Patent Row
A Florida federal judge on Wednesday denied Celgene Corp.'s bid to sanction a Teva Pharmaceutical Industries Ltd. unit for pursuing a patent infringement case involving Celgene's bone-marrow cancer drug Vidaza that Celgene calls "frivolous from the outset."
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login